Eaton Vance Management Corcept Therapeutics Inc Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

A detailed history of Eaton Vance Management transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Eaton Vance Management holds 100,000 shares of CORT stock, worth $3.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Previous 100,165 0.16%
Holding current value
$3.27 Million
Previous $2.38 Million 7.64%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $4,075 - $4,804
-165 Reduced 0.16%
100,000 $2.56 Million
Q2 2022

Aug 15, 2022
SELL
$17.33 - $25.3 $42,701 - $62,339
-2,464 Reduced 2.4%
100,165 $2.38 Million
Q1 2022

May 16, 2022
BUY
$16.53 - $25.21 $18,860 - $28,764
1,141 Added 1.12%
102,629 $2.31 Million
Q4 2021

Feb 14, 2022
BUY
$17.1 - $23.34 $3,864 - $5,274
226 Added 0.22%
101,488 $1.98 Million
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $2,204 - $2,523
-112 Reduced 0.11%
101,262 $1.97 Million
Q2 2021

Aug 16, 2021
BUY
$19.97 - $24.43 $11,223 - $13,729
562 Added 0.56%
101,374 $2.23 Million
Q1 2021

May 17, 2021
BUY
$23.49 - $30.56 $8,973 - $11,673
382 Added 0.38%
100,812 $2.4 Million
Q4 2020

Feb 12, 2021
BUY
$16.78 - $27.3 $134 - $218
8 Added 0.01%
100,430 $2.63 Million
Q3 2020

Nov 13, 2020
SELL
$12.46 - $19.98 $348 - $559
-28 Reduced 0.03%
100,422 $1.75 Million
Q2 2020

Aug 13, 2020
BUY
$11.0 - $18.26 $792 - $1,314
72 Added 0.07%
100,450 $1.69 Million
Q1 2020

May 14, 2020
BUY
$10.11 - $14.04 $192 - $266
19 Added 0.02%
100,378 $1.19 Million
Q4 2019

Feb 11, 2020
SELL
$12.06 - $16.96 $60 - $84
-5 Reduced -0.0%
100,359 $1.21 Million
Q3 2019

Nov 14, 2019
BUY
$10.41 - $14.66 $1,113 - $1,568
107 Added 0.11%
100,364 $1.42 Million
Q2 2019

Aug 16, 2019
BUY
$9.78 - $12.76 $980,513 - $1.28 Million
100,257 New
100,257 $1.12 Million

Others Institutions Holding CORT

# of Institutions
314
Shares Held
93.8M
Call Options Held
2.02M
Put Options Held
3.24M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $3.5B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email